BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 511301)

  • 1. Seroconversion following measles immunisation.
    Mittal SK; Gulati A; Kumari P; Bala V; Gupta S
    Indian Pediatr; 1979 Apr; 16(4):309-11. PubMed ID: 511301
    [No Abstract]   [Full Text] [Related]  

  • 2. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroconversion after measles vaccination in infants and children.
    Seghal S; Sharma RS; Das A; Sebastian M; Arora RR
    J Commun Dis; 1983 Jun; 15(2):75-9. PubMed ID: 6630988
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of moderate malnutrition on morbidity and antibody response following vaccination with live, attenuated measles virus vaccine.
    McMurray DN; Loomis SA; Casazza LJ; Rey H
    Bull Pan Am Health Organ; 1979; 13(1):52-7. PubMed ID: 427297
    [No Abstract]   [Full Text] [Related]  

  • 5. Child mortality related to seroconversion or lack of seroconversion after measles vaccination.
    Aaby P; Pedersen IR; Knudsen K; da Silva MC; Mordhorst CH; Helm-Petersen NC; Hansen BS; Thårup J; Poulsen A; Sodemann M
    Pediatr Infect Dis J; 1989 Apr; 8(4):197-200. PubMed ID: 2717273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Seroconversion following vaccination with a new measles vaccine strain].
    Just M; Wegmann A
    Ther Umsch; 1983 Mar; 40(3):261-3. PubMed ID: 6857567
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the combined use of killed and live measles vaccines. I. Correlation between antibody titers following injection of killed vaccine and clinical reactions after live vaccine inoculation.
    Okuno Y; Ueda S; Hosai H; Kitawaki T; Nakamura K; Chiang TP; Okabe S; Onaka M; Toyoshima K
    Biken J; 1965 Jun; 8(2):73-9. PubMed ID: 5837766
    [No Abstract]   [Full Text] [Related]  

  • 8. [Specific prophylaxis in measles. II. Tests with children of a vaccine prepared with transformed live virus (strain M60-5 Huang)].
    Cajal N; Cepleanu M; Sorodoc Y; Ionescu S; Gartner M; Ianopol L; Boghiţoiu G; Friedman O; Huluţă L; Ionescu D
    Stud Cercet Inframicrobiol; 1966; 17(5):377-87. PubMed ID: 5964006
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on measles in Thailand. II. Field trials of measles vaccine, with special reference to the K-L method.
    Tsuchinda P; Jayavasu J; Sangkawibha N; Okuno Y; Ueda S
    Biken J; 1967 Sep; 10(3):135-41. PubMed ID: 6081222
    [No Abstract]   [Full Text] [Related]  

  • 10. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of live attenuated measles and mumps vaccines in children with acute leukemia.
    Torigoe S; Hirai S; Oitani K; Ito M; Ihara T; Iwasa T; Kamiya H; Sakurai M; Ueda S; Yamanishi K
    Biken J; 1981 Dec; 24(4):147-51. PubMed ID: 7346040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroconversion following measles immunisation.
    Swami SS; Chandra S; Dudani IU
    J Commun Dis; 1987 Jun; 19(2):141-5. PubMed ID: 3454353
    [No Abstract]   [Full Text] [Related]  

  • 13. [Measles vaccination with split vaccines and living vaccines (author's transl)].
    Stehr K; Enders-Ruckle G; Spiess H
    MMW Munch Med Wochenschr; 1975 Jul; 117(27):1159-64. PubMed ID: 808710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Postvaccinal measles immunity characteristics of Leningrad children].
    Smorodinova IP; Zubov AK; Sobolevskaia AA; Kaplan AS; Smordintsev AA
    Tr Inst Im Pastera; 1979; 53():66-70. PubMed ID: 162464
    [No Abstract]   [Full Text] [Related]  

  • 15. Measles and measles vaccination in isolated Amerindian tribes. II. The 1978/79 Xingu epidemic.
    Baruzzi RG; Abdala N; Black FL
    Trop Geogr Med; 1982 Mar; 34(1):7-12. PubMed ID: 7080192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific features of measles in vaccinated children].
    Loseva AG; Peĭzner EM
    Vopr Okhr Materin Det; 1978 Sep; 23(9):49-50. PubMed ID: 716292
    [No Abstract]   [Full Text] [Related]  

  • 17. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measles vaccination in Iceland: three-year follow-up of antibody titres in adults and children.
    Black FL; Gudnadóttir M
    Bull World Health Organ; 1966; 35(6):955-7. PubMed ID: 4165239
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Congenital malaria and seroconversion following anti-measles vaccination].
    Diallo S; Denis F; Ndir O; Victorius A
    Dakar Med; 1983; 28(1):143-7. PubMed ID: 6617438
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.